Results 11 to 20 of about 5,260,254 (391)

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary

open access: yesKidney Medicine, 2023
Rationale & Objective: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection.
David Collister   +15 more
doaj   +1 more source

Therapeutic plasma exchange in pregnancy: A literature review.

open access: yesEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology, 2021
Therapeutic plasma exchange (TPE) is indicated as a treatment for a wide array of diseases, extensively addressed in the Guidelines of the American Society for Apheresis.
M. Wind   +6 more
semanticscholar   +1 more source

Clinical efficacy of plasma exchange in patients with autoimmune encephalitis

open access: yesAnnals of Clinical and Translational Neurology, 2021
To determine the clinical and antibody response after therapeutic plasma exchange (TPE) in patients with severe refractory antibody‐associated autoimmune encephalitis (AE).
Yan Zhang   +5 more
semanticscholar   +1 more source

Therapeutic plasma exchange in liver failure

open access: yesWorld Journal of Hepatology, 2021
The multi-organ failure syndrome associated with acute and acute-on-chronic liver failure (ACLF) is thought to be mediated by overwhelming systemic inflammation triggered by both microbial and non-microbial factors.
Abimbola Chris-Olaiya   +3 more
semanticscholar   +1 more source

Plasma Exchange and Plasma Adsorption

open access: diamondJAPANES JOURNAL OF MEDICAL INSTRUMENTATION, 1992
T Agishi
openaire   +3 more sources

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND More effective and safer treatments are needed for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. METHODS We conducted a randomized trial with a 2-by-2 factorial design to evaluate the use of plasma exchange and two ...
M. Walsh   +34 more
semanticscholar   +1 more source

Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome

open access: yesFrontiers in Immunology, 2023
Plasma exchange rapidly depletes pathogenic anti-neutrophil cytoplasmic autoantibodies (ANCAs) and is considered for induction therapy in severe ANCA-associated vasculitis.
Ann-Kathrin Schäfer   +5 more
doaj   +1 more source

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.

open access: yesBlood, 2020
The anti-von Willebrand factor nanobody caplacizumab was licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) based on prospective controlled trials. However, few data are available on post-marketing surveillance.
P. Coppo   +27 more
semanticscholar   +1 more source

Increased plasma viscosity as a reason for inappropriate erythropoietin formation [PDF]

open access: yes, 1993
The aim of this study was to examine whether altered plasma viscosity could contribute to the inappropriately low production rate of erythropoietin (EPO) observed in patients suffering from hypergammaglobulinemias associated with multiple myeloma or ...
Eckardt, Kai-Uwe   +7 more
core   +2 more sources

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19

open access: yesCritical Care, 2020
The novel coronavirus (“SARS-CoV-2”) outbreak has created a sense of panic globally and has the medical community rapidly searching for answers. An estimated 100,000 individuals have already been infected with nearly 3300 deaths attributed to the disease
Philip Keith   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy